Real-world evidence for option value in metastatic melanoma

Real-world evidence for option value in metastatic melanoma

BACKGROUND: The concept of real option value (ROV) suggests there is added value in treatments that extend life because they enable a patient to live long enough to benefit from future innovative treatments. Real-world evidence of this novel value element is scant, limiting its consideration in form...

Full description

Bibliographic Details
Main Authors: Garrison, L.P., Jr (Author), Lee, W. (Author), Li, M. (Author), To, T.M (Author), Veenstra, D.L (Author), Wong, W.B (Author)
Format: Article
Language:English
Published: Academy of Managed Care Pharmacy (AMCP) 2021
Subjects:
advanced cancer
antineoplastic agent
Antineoplastic Combined Chemotherapy Protocols
Article
cancer immunotherapy
cancer survival
carboplatin
cisplatin
clinical practice
cohort analysis
dacarbazine
electronic health record
Electronic Health Records
evidence based medicine
Evidence-Based Medicine
health care concepts
human
Humans
immunotherapy
Immunotherapy
ipilimumab
Ipilimumab
major clinical study
melanoma
Melanoma
metastasis
metastatic melanoma
Neoplasm Metastasis
overall survival
paclitaxel
pathology
real option value
Retrospective Studies
retrospective study
temozolomide
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items